CB
DGX icon

Cooke & Bieler’s Quest Diagnostics DGX Stock Holding History

Cooke & Bieler’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,950
Closed -$345K – 106
2014
Q1 		$345K Sell
5,950
-1,742,488
-100% -$93.4M 0.01% 93
2013
Q4 		$93.6M Sell
1,748,438
-81,030
-4% -$4.81M 2.13% 15
2013
Q3 		$113M Sell
1,829,468
-49,380
-3% -$2.96M 2.7% 4
2013
Q2 		$114M Buy
+1,878,848
New +$112M 2.72% 4

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cooke & Bieler's DGX Position: Q2 2014 in Review

Cooke & Bieler sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 5,950 shares — an estimated $345K sold.

Cooke & Bieler first reported a position in DGX in Q2 2013 and held it in 4 quarters. The position peaked at $114M in Q2 2013. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • Cooke & Bieler reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
  • Cooke & Bieler sold 5,950 Quest Diagnostics shares in Q2 2014, an estimated $345K.
  • Cooke & Bieler first reported a position in Quest Diagnostics in Q2 2013 and held it in 4 quarters.
  • Cooke & Bieler's Quest Diagnostics position peaked at $114M in Q2 2013.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on Cooke & Bieler's 13F filing for Q2 2014, filed 15 Aug 2014.